[Plasma and urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome (author's transl)]
- PMID: 6945487
[Plasma and urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome (author's transl)]
Abstract
Diagnostic value of plasma and urinary prostaglandins E2 and F2 alpha measurements was compared in 5 patients with Bartter's syndrome and 5 patients with pseudo-Bartter's syndrome. Bartter's syndrome is characterised by constant simultaneous increase of plasma and urinary PGE2; this hypersecretion is insufficiently suppressed by indomethacin treatment. Pseudo-Bartter's syndrome is characterised by normal urinary PGE2 excretion which is considerably decreased by indomethacin treatment at the same dose. The measurement of plasma and urinary prostaglandins helps to distinguish the Bartter's syndrome from pseudo-Bartter's syndrome.
Similar articles
-
Urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome.Uremia Invest. 1985-1986;9(2):203-10. doi: 10.3109/08860228509088212. Uremia Invest. 1985. PMID: 3870249
-
[A fortultousness association: Bartter's syndrome and chondrocalcinosis (author's transl)].Nouv Presse Med. 1980 Apr 19;9(18):1291-5. Nouv Presse Med. 1980. PMID: 7375363 French.
-
Bartter's syndrome with normal chloride reabsorption during indomethacin treatment.Nephron. 1987;46(2):137-43. doi: 10.1159/000184329. Nephron. 1987. PMID: 3600922
-
Prostaglandins, potassium, and Bartter's syndrome.J Lab Clin Med. 1978 Nov;92(5):663-8. J Lab Clin Med. 1978. PMID: 361914 Review. No abstract available.
-
Prostaglandins and Bartter's syndrome.Kidney Int. 1981 Jan;19(1):86-102. doi: 10.1038/ki.1981.12. Kidney Int. 1981. PMID: 7012423 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous